Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Kurilla

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Pathogens and Disease|June 24, 2014
Containing infectious diseaseMichael G Kurilla
Journal of Clinical and Translational Science|June 24, 2021
Foreword to the JCTS COVID-19 special issueChristopher P Austin, Samantha Jonson, Michael G Kurilla
Journal of Clinical and Translational Science|November 27, 2020
The CTSA program's role in improving rural public health: Community-engaged disease prevention and health care innovationXinzhi Zhang, Michael G Kurilla, Christopher P Austin
Analytical Biochemistry|April 24, 2002
PolC-type polymerase III of Streptococcus pyogenes and its use in screening for chemical inhibitorsFude Yang, Ira B Dicker, Michael G Kurilla, et al.
Journal of Public Health Management and Practice : JPHMP|August 2, 2013
High priority preparedness research and its supportSusan Coller-Monarez, Samuel L Groseclose, Michael G Kurilla, et al.
The Journal of Biological Chemistry|March 21, 2003
Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinonesEkaterina V Bobkova, Yong Ping Yan, Douglas B Jordan, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
Development of a whole-cell assay for peptidoglycan biosynthesis inhibitorsMaria D F S Barbosa, Gaoyun Yang, Jie Fang, et al.
Analytical Biochemistry|May 16, 2002
Homogenous assays for Escherichia coli DnaB-stimulated DnaG primase and DnaB helicase and their use in screening for chemical inhibitorsYi Zhang, Fude Yang, Yeh-Chih Kao, et al.
Analytical Biochemistry|June 19, 2002
A multitarget assay for inhibitors of membrane-associated steps of peptidoglycan biosynthesisMaria D F S Barbosa, Harold O Ross, Milton C Hillman, et al.
Nature Reviews. Drug Discovery|July 30, 2016
Accelerating global innovation to address antibacterial resistance: introducing CARB-XKevin Outterson, John H Rex, Tim Jinks, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pathogens and Disease|June 24, 2014
Containing infectious diseaseMichael G Kurilla
Journal of Clinical and Translational Science|June 24, 2021
Foreword to the JCTS COVID-19 special issueChristopher P Austin, Samantha Jonson, Michael G Kurilla
Journal of Clinical and Translational Science|November 27, 2020
The CTSA program's role in improving rural public health: Community-engaged disease prevention and health care innovationXinzhi Zhang, Michael G Kurilla, Christopher P Austin
Analytical Biochemistry|April 24, 2002
PolC-type polymerase III of Streptococcus pyogenes and its use in screening for chemical inhibitorsFude Yang, Ira B Dicker, Michael G Kurilla, et al.
Journal of Public Health Management and Practice : JPHMP|August 2, 2013
High priority preparedness research and its supportSusan Coller-Monarez, Samuel L Groseclose, Michael G Kurilla, et al.
The Journal of Biological Chemistry|March 21, 2003
Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinonesEkaterina V Bobkova, Yong Ping Yan, Douglas B Jordan, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
Development of a whole-cell assay for peptidoglycan biosynthesis inhibitorsMaria D F S Barbosa, Gaoyun Yang, Jie Fang, et al.
Analytical Biochemistry|May 16, 2002
Homogenous assays for Escherichia coli DnaB-stimulated DnaG primase and DnaB helicase and their use in screening for chemical inhibitorsYi Zhang, Fude Yang, Yeh-Chih Kao, et al.
Analytical Biochemistry|June 19, 2002
A multitarget assay for inhibitors of membrane-associated steps of peptidoglycan biosynthesisMaria D F S Barbosa, Harold O Ross, Milton C Hillman, et al.
Nature Reviews. Drug Discovery|July 30, 2016
Accelerating global innovation to address antibacterial resistance: introducing CARB-XKevin Outterson, John H Rex, Tim Jinks, et al.
Pageof 2